Form 8-K - Current report:
SEC Accession No. 0001558370-25-004746
Filing Date
2025-04-14
Accepted
2025-04-14 08:00:14
Documents
18
Period of Report
2025-04-11
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20250411x8k.htm   iXBRL 8-K 51248
2 EX-99.1 chrs-20250411xex99d1.htm EX-99.1 23265
3 EX-99.2 chrs-20250411xex99d2.htm EX-99.2 549299
4 GRAPHIC chrs-20250411xex99d1001.jpg GRAPHIC 6643
  Complete submission text file 0001558370-25-004746.txt   832787

Data Files

Seq Description Document Type Size
5 EX-101.SCH chrs-20250411.xsd EX-101.SCH 4593
6 EX-101.DEF chrs-20250411_def.xml EX-101.DEF 3160
7 EX-101.LAB chrs-20250411_lab.xml EX-101.LAB 12266
8 EX-101.PRE chrs-20250411_pre.xml EX-101.PRE 11153
20 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20250411x8k_htm.xml XML 4903
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 25834239
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)